Research spans immune‑cell signaling and inflammation using quantitative proteomics/phosphoproteomics, coupled with chemical biology to design small‑molecule modulators of lipid‑binding proteins, and translational studies bridging animal models and human data to target cytokine‑driven inflammatory pain.